ICYMI: The latest as America ’s biopharmaceutical companies work to beat COVID-19

America ’s biopharmaceutical companies are working around the clock to defeat COVID-19, a disease caused by a novel strain of the coronavirus. The biopharmaceutical industry continues to make significantprogress toward identifying solutions to diagnose, treat and prevent infections from the virus.
Source: The Catalyst - Category: Pharmaceuticals Tags: Research and Development PhRMA Member Company International Reference Pricing Coronavirus Source Type: news